About: http://data.cimple.eu/news-article/868f8928bb5e5d7ca9ef36c48b7a0c99e03c63a8b0a3ea8e245f32f2

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/868f8928bb5e5d7ca9ef36c48b7a0c99e03c63a8b0a3ea8e245f32f2 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	British scientists announced on Friday they had developed a test to detect womb cancer using urine samples, explaining the method could replace a painful and invasive procedure currently in use. At present, clinicians diagnose the cancer by taking a biopsy, a process which requires a narrow telescope called a hysteroscope, to examine inside of the uterus and remove cells. Nearly a third of women who undergo the procedure have the process repeated because of technical difficulties or intolerable pain, the research showed. Thousands of women in Britain who do not have womb cancer also undergo the procedure, with huge financial implications for the country's state-run National Health Service (NHS). The study from Manchester University has developed a new detection tool which examines urine or vaginal samples that can be collected by women on their own at home. The findings, published in the journal Nature Communications, showed analysis of the samples correctly diagnosed 91.7 percent of women with womb cancer. The proportion of women without womb cancer who tested negative with the new tool was 88.9 percent, the study showed. "Our results show that womb cancer cells can be detected in urine and vaginal samples using a microscope," said Professor Emma Crosbie, who led the study. "Women who test positive with this test could be referred for diagnostic investigations while women who test negative are safely reassured without the need for unpleasant, invasive, anxiety-provoking and expensive procedures." The new tool was first trialled on 103 women with known cancer and 113 with unexplained postmenopausal bleeding and could be brought into clinical practice once expanded trials have concluded. Womb cancer is the sixth most common cancer in women, with an estimated 382,000 new diagnoses and 89,900 deaths from the disease in 2018 worldwide, the university said. While most women receive early treatment after the onset of symptoms, which include bleeding after menopause, 20 percent of women who are diagnosed at an advanced stage have only a 15 percent chance of surviving beyond five years. csp/phz/spm
schema:headline	UK scientists develop urine test to detect womb cancer
schema:mentions	Biopsy Technical Difficulties (Racer X album) Menopause Telescope Uterus Bleeding Hertz Microscope Nature Urine Pain National Health Service Cancer United Kingdom Hysteroscopy Vaginal bleeding University of Manchester Clinical urine tests Emma Darwin
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-02-12 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	82 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software